Fisher Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.18B Buy
26,436,284
+1,562,957
+6% +$180M 1.08% 25
2025
Q4
$2.62B Buy
24,873,327
+805,201
+3% +$75.6M 0.89% 31
2025
Q3
$2.02B Sell
24,068,126
-945,571
-4% -$77.9M 0.73% 38
2025
Q2
$1.98B Buy
25,013,697
+567,900
+2% +$45.1M 0.79% 36
2025
Q1
$2.19B Buy
24,445,797
+8,334,193
+52% +$778M 0.95% 30
2024
Q4
$1.6B Buy
16,111,604
+1,458,169
+10% +$150M 0.64% 43
2024
Q3
$1.66B Buy
14,653,435
+387,420
+3% +$46M 0.68% 41
2024
Q2
$1.77B Buy
14,266,015
+395,572
+3% +$51M 0.77% 38
2024
Q1
$1.83B Buy
13,870,443
+319,201
+2% +$39.3M 0.85% 33
2023
Q4
$1.48B Buy
13,551,242
+212,852
+2% +$22.1M 0.78% 36
2023
Q3
$1.37B Buy
13,338,390
+703,069
+6% +$75.8M 0.78% 35
2023
Q2
$1.46B Buy
12,635,321
+289,608
+2% +$32.9M 0.81% 27
2023
Q1
$1.31B Buy
12,345,713
+165,927
+1% +$17.9M 0.8% 26
2022
Q4
$1.35B Buy
12,179,786
+143,329
+1% +$14.7M 0.91% 25
2022
Q3
$1.04B Sell
12,036,457
-87,363
-0.7% -$7.8M 0.78% 33
2022
Q2
$1.11B Buy
12,123,820
+291,723
+2% +$25.9M 0.78% 36
2022
Q1
$971M Buy
11,832,097
+422,415
+4% +$33.3M 0.57% 50
2021
Q4
$874M Buy
11,409,682
+776,418
+7% +$61.8M 0.49% 54
2021
Q3
$799M Buy
10,633,264
+316,452
+3% +$24.1M 0.5% 60
2021
Q2
$802M Sell
10,316,812
-14,625
-0.1% -$1.09M 0.5% 57
2021
Q1
$760M Buy
10,331,437
+296,702
+3% +$21.9M 0.54% 51
2020
Q4
$783M Buy
10,034,735
+311,103
+3% +$23.8M 0.59% 50
2020
Q3
$770M Buy
9,723,632
+183,816
+2% +$14.4M 0.67% 41
2020
Q2
$704M Buy
9,539,816
+204,744
+2% +$15.4M 0.69% 39
2020
Q1
$685M Buy
9,335,072
+18,316
+0.2% +$1.44M 0.85% 35
2019
Q4
$809M Sell
9,316,756
-111,586
-1% -$9.17M 0.82% 39
2019
Q3
$757M Buy
9,428,342
+245,841
+3% +$19.7M 0.83% 35
2019
Q2
$735M Buy
9,182,501
+293,620
+3% +$22.5M 0.81% 36
2019
Q1
$705M Buy
8,888,881
+58,102
+0.7% +$4.35M 0.83% 33
2018
Q4
$644M Buy
8,830,779
+398,421
+5% +$28.1M 0.88% 33
2018
Q3
$571M Buy
8,432,358
+123,598
+1% +$7.87M 0.69% 40
2018
Q2
$481M Buy
8,308,760
+293,386
+4% +$16.6M 0.62% 51
2018
Q1
$417M Buy
8,015,374
+314,490
+4% +$17M 0.55% 58
2017
Q4
$413M Buy
7,700,884
+58,538
+0.8% +$3.25M 0.54% 61
2017
Q3
$467M Buy
7,642,346
+201,223
+3% +$12.2M 0.65% 50
2017
Q2
$455M Buy
7,441,123
+248,740
+3% +$15.1M 0.69% 48
2017
Q1
$436M Buy
7,192,383
+63,610
+0.9% +$3.86M 0.7% 47
2016
Q4
$400M Sell
7,128,773
-16,013
-0.2% -$937K 0.7% 48
2016
Q3
$425M Buy
7,144,786
+60,992
+0.9% +$3.57M 0.76% 45
2016
Q2
$401M Buy
7,083,794
+64,044
+0.9% +$3.41M 0.74% 47
2016
Q1
$376M Sell
7,019,750
-129,779
-2% -$6.36M 0.71% 50
2015
Q4
$360M Buy
7,149,529
+63,261
+0.9% +$3.19M 0.69% 51
2015
Q3
$334M Sell
7,086,268
-78,433
-1% -$4.17M 0.7% 49
2015
Q2
$389M Buy
7,164,701
+164,586
+2% +$9.23M 0.76% 47
2015
Q1
$384M Buy
7,000,115
+40,861
+0.6% +$2.31M 0.77% 46
2014
Q4
$377M Buy
6,959,254
+112,172
+2% +$6.25M 0.78% 48
2014
Q3
$387M Buy
6,847,082
+72,555
+1% +$4.07M 0.83% 49
2014
Q2
$374M Buy
6,774,527
+6,014,666
+792% +$328M 0.79% 50
2014
Q1
$41.2M Sell
759,861
-392,902
-34% -$20.3M 0.09% 162
2013
Q4
$55.1M Buy
1,152,763
+225
+0% +$10.3K 0.12% 137
2013
Q3
$52.4M Sell
1,152,538
-53,389
-4% -$2.44M 0.13% 132
2013
Q2
$53.5M Buy
+1,205,927
New +$53.9M 0.14% 120

Other funds holding MRK

Fisher Asset Management's MRK Position: Q1 2026 in Review

Fisher Asset Management increased its Merck (MRK) stake by 6.3% in Q1 2026, buying an estimated $180M and bringing the position to 26,436,284 shares worth $3.18B. The position accounts for 1.08% of the portfolio, ranked #25.

Fisher Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fisher Asset Management held 26,436,284 shares of Merck worth $3.18B as of Q1 2026.
  • Fisher Asset Management bought 1,562,957 Merck shares in Q1 2026, an estimated $180M.
  • Merck made up 1.08% of Fisher Asset Management's portfolio in Q1 2026, its #25 holding.
  • Fisher Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.